-
MEAN OVERALL SURVIVAL FROM THE PHASE 3 MIRASOL TRIAL OF MIRVETUXIMAB SORAVTANSINE VS INVESTIGATOR’S CHOICE OF CHEMOTHERAPY IN WOMEN WITH FR?-HIGH PLATINUM-RESISTANT OVARIAN CANCER (GOG 3045/ENGOT-OV55; NCT04209855)
Mar 18, 2026, 21:38 PM -
IMPACT OF COVID-19 PANDEMIC ON HEALTHCARE UTILIZATION IN THE US AS OBSERVED IN FEDERATED ELECTRONIC HEALTH RECORDS: 2016 TO 2022
Mar 18, 2026, 21:38 PM -
CHARACTERIZING THE PATIENTS WITH FIBROMYALGIA: A US REAL-WORLD CLAIMS ANALYSIS
Mar 18, 2026, 21:38 PM -
REAL-WORLD SURVIVAL AND PREDICTORS OF MORTALITY IN HEMATOLOGIC MALIGNANCIES DURING AN ERA OF THERAPEUTIC ADVANCEMENT AND HEALTHCARE DISRUPTION: A POPULATION-BASED SEER STUDY
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN PINEAL NEOPLASM AND ALZHEIMER’S DISEASE PROGRESSION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT: A POPULATION-BASED COHORT STUDY
Mar 18, 2026, 21:38 PM -
ASSESSING DRIVERS OF PAYER CONTROL IN RARE DISEASE
Mar 18, 2026, 21:38 PM -
VALIDATION OF AN AI-ASSISTED EVIDENCE SYNTHESIS IN HEOR
Mar 18, 2026, 21:38 PM -
APPLYING ARTIFICIAL INTELLIGENCE TO REAL-WORLD DATA IN NSCLC - TRANSPARENT AND REPRODUCIBLE METHODS FOR PRECISION EVIDENCE
Mar 18, 2026, 21:38 PM -
A FRAMEWORK FOR INCORPORATING DISTANCE-TO-CARE METRICS IN CANCER OUTCOMES RESEARCH: EXPLORATORY INSIGHTS USING REAL-WORLD DATA FROM A NETWORK OF COMMUNITY PRACTICES
Mar 18, 2026, 21:38 PM -
USING AI TO MAP HEOR EVIDENCE GAPS: FINDINGS FROM A LARGE-SCALE LLM-BASED CLASSIFICATION ANALYSIS
Mar 18, 2026, 21:38 PM -
MANAGING LIMITATIONS OF NET PRICE ESTIMATES AT LAUNCH
Mar 18, 2026, 21:38 PM -
SHIFTING THE CURVE: VALUING HEALTHCARE UTILIZATION ACROSS PRECLINICAL AND SYMPTOMATIC ALZHEIMER’S DISEASE
Mar 18, 2026, 21:38 PM -
A POPULATION-BASED EPIDEMIOLOGICAL ANALYSIS WITH PROJECTIONS OF FETAL AND NEONATAL TRANSIENT METABOLIC DISORDERS IN HUNGARY
Mar 18, 2026, 21:38 PM -
FACTORS ASSOCIATED WITH TIME TO TREATMENT INITIATION FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS IN AN ACADEMIC MEDICAL SYSTEM
Mar 18, 2026, 21:38 PM -
SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Mar 18, 2026, 21:38 PM -
ARTIFICIAL INTELLIGENCE-DRIVEN CLINICAL DRUG REPORT GENERATION
Mar 18, 2026, 21:38 PM -
DESCRIPTION OF THE CHARACTERISTICS AND BURDEN OF NEUROFIBROMATOSIS TYPE 1 WITH PLEXIFORM NEUROFIBROMA IN A SAMPLE OF ADULT PATIENTS IN THE USA: RESULTS FROM A REAL-WORLD SURVEY
Mar 18, 2026, 21:38 PM -
PERFORMANCE OF AI METHODS FOR TITLE/ABSTRACT SCREENING: COMPARING CRITERIA-BASED AND ADVANCEMENT PROBABILITY-BASED SCREENING APPROACHES
Mar 18, 2026, 21:38 PM -
A STRUCTURED FRAMEWORK FOR CATEGORISING UNMET NEED IN HTA: APPLICATION TO SOLID TUMOR ASSESSMENTS ACROSS EIGHT OECD COUNTRIES
Mar 18, 2026, 21:38 PM -
A NEXT-GENERATION FRAMEWORK FOR AI-AUGMENTED, SUBMISSION-GRADE LITERATURE REVIEWS: A MULTI-PROJECT ANALYSIS OF SPEED, ACCURACY, AND WORKFLOW EVOLUTION
Mar 18, 2026, 21:38 PM
